ایفرمکتین

Ivermectin is an antiparasitic medication. After its discovery in 1975, its first uses were in veterinary medicine to prevent and treat heartworm and acariasis. Approved for human use in 1987, it is used to treat infestations including head lice, scabies, river blindness (onchocerciasis), strongyloidiasis, trichuriasis, ascariasis and lymphatic filariasis. It works through many mechanisms to kill the targeted parasites, and can be taken by mouth, or applied to the skin for external infestations. It belongs to the avermectin family of medications.

OverviewAI-generated

Ivermectin is a chemical compound with the formula C₉₅H₁₄₆O₂₈. Its mass is 1736.2, and it has a defined daily dose of 12. The molecule possesses a topological polar surface area of 340, with 6 hydrogen bond donors and 28 hydrogen bond acceptors. It carries a charge of 0.

The compound is identified by the InChIKey SPBDXSGPUHCETR-JFUDTMANSA-N and the NCI Thesaurus ID C61796. It is associated with a PubChem CID of 9812710. A Commons category exists for ivermectin. The subject is referenced by 1,644 other encyclopedia articles and has a PubMed count of 11981.

Synthesized by Vinony from 15 facts across 4 sources: Wikidata, PubMed, PubChem, Vinony graph. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.

Chemical data

Formula: C95H146O28
Molecular weight: 1736.2 g/mol
IUPAC name: (1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one;(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethyl-6'-propan-2-ylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one
SMILES: CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C.C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)O[C@@H]1C(C)C
InChIKey: SPBDXSGPUHCETR-JFUDTMANSA-N
Polar surface area: 340 Å²
H-bond donors: 6
H-bond acceptors: 28
Formal charge: 0

via PubChem

Research

11,981 papers

Ivermectin, a potential anticancer drug derived from an antiparasitic drug.Pharmacological research · 2021
Ivermectin: a mini-review.Clinical toxicology (Philadelphia, Pa.) · 2022
Ivermectin in Cancer Treatment: Should Healthcare Providers Caution or Explore Its Therapeutic Potential?Current oncology reports · 2025
Ivermectin for preventing and treating COVID-19.The Cochrane database of systematic reviews · 2022
Ivermectin and non-parasitic disorders: An update.Current opinion in pharmacology · 2025

via PubMed

Wikidata facts

Subclass of: mixture
Mass: 1736.2
Image: Ivermectin skeletal.svg
Has use: medication

Show 9 more facts

canonical SMILES: CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C.CC1CCC2(CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)OC1C(C)C
chemical formula: C₉₅H₁₄₆O₂₈
World Health Organisation international non-proprietary name: ivermectin
medical condition treated: onchocerciasis
defined daily dose: 12
NCI Thesaurus ID: C61796
subject has role: essential medicine
described at URL: www.theatlantic.com/science/archive/2021/10/ivermectin-research-problems/620473/?utm_source=pocket-newtab-global-en-GB
Commons category: Ivermectin